(71 days)
No
The summary describes a standard RIS/PACS system with image processing and display capabilities, but there is no mention of AI or ML in the intended use, device description, or performance studies.
No
This device is a software-only application for processing, storing, and displaying medical images. It does not provide treatment or directly affect the patient's body, which are characteristics of therapeutic devices.
Yes
The device processes medical images, provides toolsets for measurements, solves clinical calculations, and creates structured reports, all of which are activities associated with reaching a medical diagnosis.
Yes
The device description explicitly states, "As a software-only device, it does not control image acquisition." and describes it as a "fully web based, enterprise-wide application".
Based on the provided text, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs are used to examine specimens from the human body. The intended use and device description clearly state that this software processes and displays medical images acquired from imaging modalities (like CT, MRI, X-ray, etc.). These are images of the body itself, not specimens taken from the body (like blood, urine, tissue samples, etc.).
- The functions described are related to image management, processing, and display. The software handles DICOM images, performs measurements on them, imports data from modalities, and creates reports. These are typical functions of a Picture Archiving and Communication System (PACS) and Radiology Information System (RIS), which are not considered IVDs.
The text focuses on the handling and interpretation of medical images, which falls under the category of medical imaging software, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
Medsynapse RIS PACS Software is intended for use as a fully web based application on an off-the shelf PC which is networked with a Medsynapse RIS PACS server. The Medsynapse RIS PACS software can process medical images from DICOM compliant modalities and non DICOM sources. The Medsynapse RIS PACS software provides toolsets for performing measurements on DICOM images, importing and presenting data from modalities (DICOM and non-DICOM), solving clinical calculations, and creating and distributing structured reports.
It enables the display, comparison and fusion of 3D (MIP/MPR) of CT, MR, PET and SPECT studies. Typical users are radiologists, cardiologists, technologists, sonographers, technicians, nurses and clinicians. MIP, MPR, and Fusion are not intended for Mammography use.
Medsynapse VNA is an open standards based archiving methodology used for storing images in non-proprietary format.
The Medsynapse RIS PACS Software may be used to process DICOM MG "For Processing" images and also for the display, manipulation, and interpretation of lossless compressed mammography images that have been received in the DICOM For Presentation format and displayed on FDA cleared, DICOM compatible displays for mammography.
Product codes (comma separated list FDA assigned to the subject device)
LLZ
Device Description
Medsynapse RIS (Radiology Information System) PACS is a fully web based, enterprise-wide application intended for communication, storage, display, printing, and processing of medical images. Its software components perform operations related to image manipulation and measurements relevant to radiology and cardiology. As a software-only device, it does not control image acquisition. Typical users of Medsynapse RIS PACS are radiologists, technologists, sonographers, technicians, nurses, and clinicians. The software runs on standard PC equipment using MS Windows operating systems meeting minimum system requirements. Medsynapse VNA (Vendor Neutral Archive) is an open standards-based archiving methodology used for storing images in non-proprietary format.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
DICOM compliant modalities and non DICOM sources, (MIP/MPR) of CT, MR, PET and SPECT studies, Plane X-ray radiography, X-ray computed tomography, magnetic resonance imaging, ultrasound, nuclear medicine, Mammography
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
radiologists, cardiologists, technologists, sonographers, technicians, nurses and clinicians.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Bench/Performance Testing: The results of bench testing (software validation and risk analysis for a moderate level of concern device) shows that this new device poses no new issues of safety or effectiveness, has essentially the same technological characteristics as the predicate, and is therefore substantially equivalent to the predicate device. Software and labeling was developed in accordance with the following FDA guidance documents: Guidance for Industry and FDA Staff Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices; Guidance for Industry, FDA Reviewers and Compliance on Off-The-Shelf Software Use in Medical Devices; Guidance for Industry Cybersecurity for Networked Medical Devices Containing Off-the-Shelf (OTS) Software, and Content of Premarket Submissions for Management of Cybersecurity in Medical Devices, Guidance for Industry and Food and Drug Administration Staff. Risk management was conducted in accordance with IEC 14971, Application of Risk Management to Medical Devices.
Clinical Testing: Not required for a showing of substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
November 22, 2019
Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
Medsynaptic Private Ltd. % Daniel Kamm, P.E. Principal Engineer Kamm & Associates 8870 Ravello Ct NAPLES FL 34114
Re: K192508
Trade/Device Name: MEDSYNAPSE RIS PACS & MEDSYNAPSE VNA Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: Class II Product Code: LLZ Dated: November 19, 2019 Received: November 20, 2019
Dear Mr. Kamm:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting
1
combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
For
Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K192508
Device Name MEDSYNAPSE RIS PACS & MEDSYNAPSE VNA
Indications for Use (Describe)
Medsynapse RIS PACS Software is intended for use as a fully web based application on an off-the shelf PC which is networked with a Medsynapse RIS PACS server. The Medsynapse RIS PACS software can process medical images from DICOM compliant modalities and non DICOM sources. The Medsynapse RIS PACS software provides toolsets for performing measurements on DICOM images, importing and presenting data from modalities (DICOM and non-DICOM), solving clinical calculations, and creating and distributing structured reports.
It enables the display, comparison and fusion of 3D (MIP/MPR) of CT, MR, PET and SPECT studies. Typical users are radiologists, cardiologists, technologists, sonographers, technicians, nurses and clinicians. MIP, MPR, and Fusion are not intended for Mammography use.
Medsynapse VNA is an open standards based archiving methodology used for storing images in non-proprietary format.
The Medsynapse RIS PACS Software may be used to process DICOM MG "For Processing" images and also for the display, manipulation, and interpretation of lossless compressed mammography images that have been received in the DICOM For Presentation format and displayed on FDA cleared, DICOM compatible displays for mammography.
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the words "510(K) Summary K192508" at the top. Below that is the logo for MED Synaptic. The logo is green and yellow.
Medsynaptic Private Ltd 5th Floor, Mantri Galleria, Off S.B. Road, Model Colony, Shivaji Nagar, Pune - 411016, India. Phone : +91-20-25650411 Telefax +91-20-25650412
URL: http://www.medsynaptic.com Contact: Dr Ashish Dhawad, Chief Executive Officer Date prepared: November 18, 2019
-
- Trade Name: MEDSYNAPSE RIS PACS & MEDSYNAPSE VNA Common Name: PACS Software Classification Name: System, image processing, radiological Regulation Description: Picture archiving and communications system Product code LLZ, Regulation: 892.2050 Class of device: Class II.
-
- The legally marketed device to which we are claiming equivalence: K190232, Synapse PACS, FUJIFILM Corporation Common Name: PACS Software Classification Name: System, image processing, radiological Regulation Description: Picture archiving and communications system Product code LLZ, Regulation: 892.2050 Class of device: Class II.
-
- Reference device: K093247, Medsynaptic Private Ltd Trade Name: Medsynapse PACS Software Common Name: PACS Software Classification Name: System, image processing, radiological Regulation Description: Picture archiving and communications system Product code LLZ, Regulation: 892.2050 Class of device: Class II.
-
- Description of device: Medsynapse RIS (Radiology Information System) PACS is a fully web based, enterprise-wide application intended for communication, storage, display, printing, and processing of medical images. Its software components perform operations related to image manipulation and measurements relevant to radiology and cardiology. As a software-only device, it does not control image acquisition. Typical users of Medsynapse RIS PACS are radiologists, technologists, sonographers, technicians, nurses, and clinicians. The software runs on standard PC equipment using MS Windows operating systems meeting minimum system requirements. Medsynapse VNA (Vendor Neutral Archive) is an open standards-based archiving methodology
4
used for storing images in non-proprietary format.
-
- Indications for use: Medsynapse RIS PACS Software is intended for use as a fully web based application on an off-the shelf PC which is networked with a Medsynapse RIS PACS server. The Medsynapse RIS PACS software can process medical images from DICOM compliant modalities and non DICOM sources. The Medsynapse RIS PACS software provides toolsets for performing measurements on DICOM images, importing and presenting data from modalities (DICOM and non-DICOM), solving clinical calculations, and creating and distributing structured reports.
It enables the display, comparison and fusion of 3D (MIP/MPR) of CT, MR, PET and SPECT studies. Typical users are radiologists, cardiologists, technologists, sonographers, technicians, nurses and clinicians. MIP, MPR, and Fusion are not intended for Mammography use.
- Indications for use: Medsynapse RIS PACS Software is intended for use as a fully web based application on an off-the shelf PC which is networked with a Medsynapse RIS PACS server. The Medsynapse RIS PACS software can process medical images from DICOM compliant modalities and non DICOM sources. The Medsynapse RIS PACS software provides toolsets for performing measurements on DICOM images, importing and presenting data from modalities (DICOM and non-DICOM), solving clinical calculations, and creating and distributing structured reports.
Medsynapse VNA is an open standards based archiving methodology used for storing images in non-proprietary format.
The Medsynapse RIS PACS Software may be used to process DICOM MG "For Processing" images and also for the display, manipulation, and interpretation of lossless compressed or noncompressed mammography images that have been received in the DICOM For Presentation format and displayed on FDA cleared, DICOM compatible displays for mammography.. (Rx Only)
| Characteristic | K190232, Fujifilm Synapse PACS. | MEDSYNAPSE RIS PACS & | Technological |
|---|---|---|---|
| MEDSYNAPSE VNA | Comparison | ||
| Indications | FUJIFILM Synapse PACS Software is | ||
| intended for use as a web based | |||
| application on an off-the shelf PC which | |||
| meets or exceeds minimum specifications | |||
| and is networked with a FUJIFILM Synapse | |||
| PACS server. The FUJIFILM Synapse PACS | |||
| Software can process medical images from | |||
| DICOM compliant modalities and non- | |||
| DICOM sources. The FUJIFILM Synapse | |||
| PACS Software provides toolsets for | |||
| performing measurements on DICOM | |||
| images, importing and presenting data | |||
| from modalities (DICOM and non-DICOM), | |||
| solving clinical calculations, and creating | |||
| and distributing structured reports. The | |||
| FUJIFILM Synapse PACS Software is | |||
| intended to serve as the primary user | |||
| interface for the processing of medical | |||
| images for presentation on displays | |||
| appropriate to the medical task being | |||
| performed. It enables the display, | |||
| comparison and fusion of 3D (MIP/MPR) of | |||
| CT, MR, PET and SPECT studies. Typical | |||
| users are radiologists, cardiologists, | |||
| technologists, sonographers, technicians, | |||
| nurses and clinicians. MIP, MPR, and | |||
| Fusion are not intended for | |||
| mammography use. The FUJIFILM Synapse | |||
| PACS Software may be used to process | |||
| FUJIFILM's DICOM MG "For Processing" | Medsynapse RIS PACS Software is | ||
| intended for use as a fully web based | |||
| application on an off-the shelf PC which | |||
| is networked with a Medsynapse RIS | |||
| PACS server. The Medsynapse RIS PACS | |||
| software can process medical images | |||
| from DICOM compliant modalities and | |||
| non DICOM sources. The Medsynapse | |||
| RIS PACS software provides toolsets for | |||
| performing measurements on DICOM | |||
| images, importing and presenting data | |||
| from modalities (DICOM and non- | |||
| DICOM), solving clinical calculations, | |||
| and creating and distributing structured | |||
| reports. It enables the display, | |||
| comparison and fusion of 3D | |||
| (MIP/MPR) of CT, MR, PET and SPECT | |||
| studies. Typical users are radiologists, | |||
| cardiologists, technologists, | |||
| sonographers, technicians, nurses and | |||
| clinicians. MIP, MPR, and Fusion are not | |||
| intended for Mammography use. | |||
| Medsynapse VNA is an open standards | |||
| based archiving methodology used for | |||
| storing images in non-proprietary | |||
| format. The Medsynapse RIS PACS | |||
| Software may be used to process | |||
| DICOM MG "For Processing" images | |||
| and also for the display, manipulation, | |||
| and interpretation of lossless | The | ||
| indications | |||
| mean the | |||
| same thing | |||
| with slightly | |||
| different | |||
| wording. |
6. Technological characteristics: Comparison Table
5
| Characteristic | K190232, Fujifilm Synapse PACS. | MEDSYNAPSE RIS PACS &
MEDSYNAPSE VNA | Technological
Comparison |
|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------|
| | images and also for the display,
manipulation, and interpretation of
lossless compressed or non-compressed
mammography images that have been
received in the DICOM For Presentation
format and displayed on FDA cleared,
DICOM compatible displays for
mammography. | compressed or non-compressed
mammography images that have been
received in the DICOM For Presentation
format and displayed on FDA cleared,
DICOM compatible displays for
mammography | |
| Features | DICOM compatible | DICOM compatible | SAME |
| | Multipurpose, enterprise-wide
application intended for
communication, storage, display,
printing, and processing of medical
images | SAME | SAME |
| | Typical users of Synapse PACs are
radiologists, cardiologists,
technologists, sonographers,
technicians, nurses, and clinicians | SAME | SAME |
| Modalities | Plane X-ray radiography, X-ray
computed tomography, magnetic
resonance imaging, ultrasound,
nuclear medicine, and images from
DICOM compliant modalities.
Mammography with appropriate
display resolution | SAME | SAME |
| HIPAA
Compliance | YES | SAME | SAME |
| Computer/
Operating
System | Windows PC | SAME | SAME |
-
- Bench/Performance Testing: The results of bench testing (software validation and risk analysis for a moderate level of concern device) shows that this new device poses no new issues of safety or effectiveness, has essentially the same technological characteristics as the predicate, and is therefore substantially equivalent to the predicate device. Software and labeling was developed in accordance with the following FDA guidance documents: Guidance for Industry and FDA Staff Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices; Guidance for Industry, FDA Reviewers and Compliance on Off-The-Shelf Software Use in Medical Devices; Guidance for Industry Cybersecurity for Networked Medical Devices Containing Off-the-Shelf (OTS) Software, and Content of Premarket Submissions for Management of Cybersecurity in Medical Devices, Guidance for Industry and Food and Drug Administration Staff. Risk management was conducted in accordance with IEC 14971, Application of Risk Management to Medical Devices.
-
- Clinical Testing: Not required for a showing of substantial equivalence.
6
-
- Conclusion: Based on comparison to the 510(k) summary of the predicate device, its technical characteristics, the indications for use, and the near identical characteristics of the two products, we conclude that the MEDSYNAPSE RIS PACS & MEDSYNAPSE VNA is substantially equivalent to the named predicate device.